Cycle Pharmaceuticals acquiring Applied Therapeutics
Source: SeekingAlpha
2025-12-11 18:16:03 ET
More on Applied Therapeutics
- Seeking Alpha’s Quant Rating on Applied Therapeutics
- Historical earnings data for Applied Therapeutics
- Financial information for Applied Therapeutics
Read the full article on Seeking Alpha
For further details see:
Cycle Pharmaceuticals acquiring Applied Therapeutics
Applied Therapeutics Inc.
NASDAQ: APLT
APLT Trading
0.48% G/L:
$0.1045 Last:
1,417,905 Volume:
$0.1036 Open:
APLT Latest News
January 29, 2026 08:15:13 am
Applied Therapeutics Shares Letter to Stockholders Recommending Tender of Shares Following Offer Expiration Extension
December 16, 2025 11:21:00 am
Halper Sadeh LLC Encourages QIPT, FITB, GBIO, APLT Shareholders to Contact the Firm to Discuss Their Rights
APLT Stock Data
$14,862,969
141,991,863
N/A
37
N/A
Biotechnology & Life Sciences
Healthcare
US
New York
